These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30784360)

  • 1. JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells.
    Shiraiwa K; Matsuse M; Nakazawa Y; Ogi T; Suzuki K; Saenko V; Xu S; Umezawa K; Yamashita S; Tsukamoto K; Mitsutake N
    Thyroid; 2019 May; 29(5):674-682. PubMed ID: 30784360
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression.
    Heiden KB; Williamson AJ; Doscas ME; Ye J; Wang Y; Liu D; Xing M; Prinz RA; Xu X
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2178-87. PubMed ID: 25078145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma.
    Luo Y; Yang Z; Su L; Shan J; Xu H; Xu Y; Liu L; Zhu W; Chen X; Liu C; Chen J; Yao C; Cheng F; Zhang C; Ma Q; Shen J; Qian C
    Cancer Lett; 2016 Jun; 375(2):390-399. PubMed ID: 27000993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
    Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
    Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Kimura T; Doolittle WKL; Kruhlak M; Zhao L; Hwang E; Zhu X; Tang B; Wolcott KM; Cheng SY
    Thyroid; 2024 Apr; 34(4):484-495. PubMed ID: 38115586
    [No Abstract]   [Full Text] [Related]  

  • 8. ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma.
    Xu T; Zhu C; Chen J; Song F; Ren X; Wang S; Yi X; Zhang Y; Zhang W; Hu Q; Qin H; Liu Y; Zhang S; Tan Z; Pan Z; Huang P; Ge M
    J Exp Clin Cancer Res; 2023 Jul; 42(1):182. PubMed ID: 37501099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Doolittle WKL; Zhao L; Cheng SY
    Thyroid; 2022 Aug; 32(8):937-948. PubMed ID: 35822558
    [No Abstract]   [Full Text] [Related]  

  • 10. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer.
    Wang Y; Hu Z; Ma W; Niu Y; Su J; Zhang L; Zhao P
    Invest New Drugs; 2021 Jun; 39(3):764-774. PubMed ID: 33245464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
    Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
    J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
    Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma.
    Bozorg-Ghalati F; Hedayati M; Dianatpour M; Mosaffa N; Azizi F
    Asian Pac J Cancer Prev; 2019 May; 20(5):1353-1360. PubMed ID: 31127889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diallyl trisulphide, a H
    Zhang L; Xu S; Cheng X; Zheng J; Wang Y; Wu J; Wang X; Wu L; Yu H; Bao J
    Phytother Res; 2021 Jun; 35(6):3428-3443. PubMed ID: 33751676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.
    Shimamura M; Kurashige T; Mitsutake N; Nagayama Y
    Endocrine; 2017 Mar; 55(3):934-943. PubMed ID: 28040834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells.
    Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J
    Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer.
    Jiang YX; Siu MK; Wang JJ; Mo XT; Leung TH; Chan DW; Cheung AN; Ngan HY; Chan KK
    Br J Cancer; 2020 Jul; 123(2):275-287. PubMed ID: 32390009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
    Gao H; Wang W; Li Q
    Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.